Myriad Genetics Inc SEC filings MYGN

Myriad Genetics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Aug 31, 2015. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 6, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.

Myriad Genetics Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 6, 2026 Sep 30, 2026
8-K Current report
Other events
Nov 5, 2026 Nov 2, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Nov 2, 2026 Nov 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Oct 20, 2026 Oct 19, 2026
8-K Current report
Officer or director change
Oct 9, 2026 Oct 6, 2026
4 Insider transaction Sep 22, 2026 Sep 21, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 17, 2026 Sep 16, 2026
3 Initial insider ownership Sep 17, 2026 Sep 16, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Sep 4, 2026 —
4 Insider transaction Aug 17, 2026 Aug 16, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Jul 31, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
4 Insider transaction Jun 23, 2026 Jun 23, 2026
8-K Current report
Officer or director change
Jun 23, 2026 Jun 17, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
144 Notice of proposed sale Jun 8, 2026 —
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
4 Insider transaction Jun 5, 2026 Jun 4, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 4, 2026
S-8 Employee stock plan registration Jun 4, 2026 —
S-8 Employee stock plan registration Jun 4, 2026 —
4 Insider transaction Jun 2, 2026 Jun 1, 2026
3 Initial insider ownership Jun 2, 2026 Jun 1, 2026
4 Insider transaction May 14, 2026 May 14, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
4 Insider transaction May 4, 2026 May 1, 2026
4 Insider transaction Apr 15, 2026 Apr 14, 2026
4 Insider transaction Apr 15, 2026 Apr 14, 2026
ARS Annual report to shareholders Apr 14, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 14, 2026 —
DEF 14A Proxy statement Apr 14, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 23, 2026 Mar 22, 2026
4 Insider transaction Mar 16, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 9, 2026 Mar 9, 2026
EFFECT Filing Mar 4, 2026 —
424B3 Prospectus Mar 4, 2026 —
4 Insider transaction Mar 2, 2026 Mar 1, 2026
CORRESP Letter to the SEC Mar 2, 2026 —
4 Insider transaction Feb 27, 2026 Feb 25, 2026
UPLOAD Letter from the SEC Feb 27, 2026 —
S-3 Shelf registration Feb 24, 2026 —
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 23, 2026 Feb 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
4 Insider transaction Feb 3, 2026 Feb 2, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 13, 2026 —
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Dec 29, 2025 Dec 25, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
4 Insider transaction Nov 4, 2025 Nov 3, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K/A Amended current report
Results of operations
Nov 4, 2025 Nov 3, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 31, 2025 —
4 Insider transaction Oct 24, 2025 Oct 24, 2025
8-K Current report
Officer or director change
Oct 7, 2025 Oct 1, 2025
8-K Current report
Officer or director change
Oct 3, 2025 Sep 29, 2025
4 Insider transaction Sep 22, 2025 Sep 21, 2025
4 Insider transaction Sep 22, 2025 Sep 21, 2025
4 Insider transaction Sep 22, 2025 Sep 21, 2025
4 Insider transaction Sep 22, 2025 Sep 21, 2025
4 Insider transaction Sep 4, 2025 Sep 3, 2025
4 Insider transaction Aug 19, 2025 Aug 16, 2025
3 Initial insider ownership Aug 19, 2025 Aug 16, 2025
4 Insider transaction Aug 18, 2025 Aug 18, 2025
8-K Current report
Officer or director change
Aug 18, 2025 Aug 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 4, 2025 —
8-K Current report
Material agreement, New debt, Other events
Jul 31, 2025 Jul 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2025 Jun 5, 2025
S-8 Employee stock plan registration Jun 5, 2025 —
4 Insider transaction Jun 2, 2025 May 31, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
4 Insider transaction May 2, 2025 May 1, 2025
3 Initial insider ownership May 1, 2025 May 1, 2025
4 Insider transaction May 1, 2025 Apr 30, 2025
4 Insider transaction May 1, 2025 Apr 30, 2025
S-8 Employee stock plan registration May 1, 2025 —
4 Insider transaction Apr 30, 2025 Apr 30, 2025
4 Insider transaction Apr 15, 2025 Apr 14, 2025
4 Insider transaction Apr 15, 2025 Apr 14, 2025
ARS Annual report to shareholders Apr 9, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 9, 2025 —
DEF 14A Proxy statement Apr 9, 2025 Dec 31, 2024
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 25, 2025 Mar 22, 2025
4 Insider transaction Mar 25, 2025 Mar 22, 2025
4 Insider transaction Mar 25, 2025 Mar 22, 2025
4 Insider transaction Mar 25, 2025 Mar 22, 2025
4 Insider transaction Mar 25, 2025 Mar 22, 2025
4 Insider transaction Mar 25, 2025 Mar 22, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 4, 2025 Feb 7, 2025
4 Insider transaction Mar 4, 2025 Feb 7, 2025
4 Insider transaction Mar 4, 2025 Feb 7, 2025
4 Insider transaction Mar 4, 2025 Feb 7, 2025
4 Insider transaction Mar 4, 2025 Feb 7, 2025
4 Insider transaction Mar 4, 2025 Feb 7, 2025
4 Insider transaction Mar 3, 2025 Mar 1, 2025
10-K Annual report Feb 28, 2025 Dec 31, 2024
4 Insider transaction Feb 26, 2025 Feb 25, 2025
4 Insider transaction Feb 26, 2025 Feb 25, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Feb 24, 2025 Feb 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2025 —
4 Insider transaction Jan 30, 2025 Jan 29, 2025
8-K Current report
Results of operations
Jan 15, 2025 Jan 15, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
4 Insider transaction Dec 12, 2024 Dec 11, 2024
4 Insider transaction Dec 11, 2024 Dec 10, 2024
3 Initial insider ownership Dec 10, 2024 Dec 10, 2024
8-K Current report
Officer or director change
Dec 10, 2024 Dec 10, 2024
4 Insider transaction Dec 2, 2024 Nov 30, 2024
8-K Current report
Regulation FD disclosure
Nov 26, 2024 Nov 26, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
4 Insider transaction Oct 11, 2024 Oct 11, 2024
144 Notice of proposed sale Oct 11, 2024 —
4 Insider transaction Oct 10, 2024 Oct 9, 2024
4 Insider transaction Oct 10, 2024 Oct 9, 2024
4 Insider transaction Oct 10, 2024 Oct 9, 2024
8-K Current report
Results of operations
Oct 9, 2024 Oct 9, 2024
4 Insider transaction Sep 23, 2024 Sep 21, 2024
4 Insider transaction Sep 23, 2024 Sep 21, 2024
4 Insider transaction Sep 23, 2024 Sep 21, 2024
144 Notice of proposed sale Sep 16, 2024 —
4 Insider transaction Sep 12, 2024 Sep 11, 2024
4 Insider transaction Sep 12, 2024 Sep 11, 2024
144 Notice of proposed sale Sep 11, 2024 —
144 Notice of proposed sale Sep 11, 2024 —
4 Insider transaction Sep 9, 2024 Sep 9, 2024
144 Notice of proposed sale Sep 9, 2024 —
4 Insider transaction Sep 4, 2024 Sep 3, 2024
4 Insider transaction Sep 4, 2024 Sep 3, 2024
8-K Current report
Regulation FD disclosure
Sep 4, 2024 Sep 4, 2024
3 Initial insider ownership Sep 3, 2024 Sep 3, 2024
144 Notice of proposed sale Sep 3, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
MYGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Accelerated filer
SEC CIK
899923
Former names
MYRIAD GENETICS INC (until Nov 6, 2026)

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.